ALCOHOL AND MESOLIMBIC DOPAMINE PATHWAY
酒精和中脑边缘多巴胺通路
基本信息
- 批准号:2500948
- 负责人:
- 金额:$ 10.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-03-01 至 2003-02-28
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION: (Adapted from the Investigator's Abstract) The long-term goal
of this project is to elucidate further the neurochemical basis of the
reinforcing effects of ethanol and to develop new strategy aimed at
decreasing alcoholism in man. The proposed research will be carried out on
freely moving rats by using intracerebral microdialysis technique to monitor
in vivo dopamine (DA) release in the nucleus accumbens (NACC), a terminal
area of the mesolimbic DA pathway. Pharmacologically relevant doses of
ethanol will be administered systemically. First, DA and 5-HT in 5-min
dialysate samples from the NACC will be measured simultaneously following
acute ethanol to detect any changes in extracellular DA and 5-HT which occur
during the ascending phase of the brain ethanol concentration curve. In
addition, Ethanol-induced DA release in the NACC will be compared with and
without the++ treatments with: 1) perfusion with tetrodotoxin (TTX) or Ca
-free medium into the NACC, both of which are known to interrupt membrane
depolarization; 2) perfusion with quinpirole, a D2 receptor agonist, into
the ventral tegmental area (VTA) to suppress the mesolimbic DA neuronal
activity; 3) nomifensine, a DA uptake blocker. This will enable us to
determine whether and to what extent a carrier-dependent mechanism is
involved in ethanol-induced DA release in the NACC. Furthermore, the
effects of suppression (Lesioning with 5,7-DHT) or enhancement (pretreatment
with 5-hydroxytryptophan and carbidopa) of the serotonergic transmission on
ethanol-induced DA release will be evaluated. This will allow us to asses
the possible involvement of the 5-HT system in the reinforcing effects of
ethanol, the effects of agonists and antagonists at these subtypes of 5-HT2
receptors in the reinforcing effects of ethanol, the effects of agonists and
antagonists at these subtypes of 5-HT receptor on ethanol-induced DA release
in the NACC will be investigated. This will elucidate the relative
contribution of 5-HT2 receptors to the regulation of ethanol-induced DA
release and help to explain the effects of 5-HT2 antagonists on alcohol
consumption reported in the literature.
描述:(改编自研究者摘要)长期目标
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
QINGSHAN YAN其他文献
QINGSHAN YAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('QINGSHAN YAN', 18)}}的其他基金
RNAi-medicated inhibition of BDNF expression and alcohol-drinking behavior
RNAi 抑制 BDNF 表达和饮酒行为
- 批准号:
7177105 - 财政年份:2007
- 资助金额:
$ 10.03万 - 项目类别:
RNAi-medicated inhibition of BDNF expression and alcohol-drinking behavior
RNAi 抑制 BDNF 表达和饮酒行为
- 批准号:
7340147 - 财政年份:2007
- 资助金额:
$ 10.03万 - 项目类别:
相似国自然基金
DRD2/ERK/β-catenin信号联合Dopamine/ERK/TH调节环介导慢性应激促进脑胶质瘤恶性进展的研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
11C-N-CH3-Dopamine PET/MRI心脏神经显像对射血分数保留的心衰的实验研究
- 批准号:82171969
- 批准年份:2021
- 资助金额:56 万元
- 项目类别:面上项目
11C-N-CH3-Dopamine心肌Micro PET/CT显像对糖尿病心脏自主神经病变的评估
- 批准号:82060323
- 批准年份:2020
- 资助金额:34 万元
- 项目类别:地区科学基金项目
11C-N-CH3-Dopamine神经显像对心肌"缺血记忆"的实验研究
- 批准号:81460271
- 批准年份:2014
- 资助金额:46.0 万元
- 项目类别:地区科学基金项目
11C-dopamine PET/CT显像对急性心肌缺血状况下交感神经功能变化的实验研究
- 批准号:81060019
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Understanding the role of dopamine antagonists on peripheral glucose regulation
了解多巴胺拮抗剂对外周血糖调节的作用
- 批准号:
RGPIN-2022-03019 - 财政年份:2022
- 资助金额:
$ 10.03万 - 项目类别:
Discovery Grants Program - Individual
MOLECULAR MODELING OF DOPAMINE ANTAGONISTS: COCAINE
多巴胺拮抗剂的分子建模:可卡因
- 批准号:
6122411 - 财政年份:1998
- 资助金额:
$ 10.03万 - 项目类别:
MOLECULAR MODELING OF DOPAMINE ANTAGONISTS: COCAINE
多巴胺拮抗剂的分子建模:可卡因
- 批准号:
6282446 - 财政年份:1998
- 资助金额:
$ 10.03万 - 项目类别:
MOLECULAR MODELING OF DOPAMINE ANTAGONISTS: COCAINE
多巴胺拮抗剂的分子建模:可卡因
- 批准号:
6295101 - 财政年份:1998
- 资助金额:
$ 10.03万 - 项目类别:
DOPAMINE ANTAGONISTS IN TREATMENT OF LESCH NYHAN DISEASE
多巴胺拮抗剂治疗 LESCH NYHAN 病
- 批准号:
3948266 - 财政年份:
- 资助金额:
$ 10.03万 - 项目类别:
ACTION OF DOPAMINE ANTAGONISTS ON COCAINE INDUCED BEHAVIOR
多巴胺拮抗剂对可卡因诱发行为的作用
- 批准号:
3870037 - 财政年份:
- 资助金额:
$ 10.03万 - 项目类别:
ACTION OF DOPAMINE ANTAGONISTS ON COCAINE-INDUCED BEHAVIOR
多巴胺拮抗剂对可卡因诱发行为的作用
- 批准号:
3891542 - 财政年份:
- 资助金额:
$ 10.03万 - 项目类别: